Holles Natalie C. 4
4 · Third Harmonic Bio, Inc. · Filed May 10, 2024
Insider Transaction Report
Form 4
Holles Natalie C.
DirectorCEO
Transactions
- Exercise/Conversion
Common Stock
2024-05-09$4.20/sh+20,222$84,932→ 1,239,058 total - Sale
Common Stock
2024-05-09$12.18/sh−20,222$246,300→ 1,218,836 total - Exercise/Conversion
Employee Stock Option (right to buy)
2024-05-09−20,222→ 433,854 totalExercise: $4.20Exp: 2032-02-16→ Common Stock (20,222 underlying)
Footnotes (3)
- [F1]The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- [F2]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.15 to $12.42 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]6.25% of the total shares vested on May 17, 2022, and thereafter 6.25% of the total shares underlying the award shall vest in equal quarterly installments until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date.